“…Placental organoids, of which functionality is the ability to express or produce human chorionic gonadotropin, have been derived from CTBs purified from 6-7 WG placentas, but not from 10-12 WG placentas [131,144]. This was achieved by using a cocktail containing activators of the WNT pathway (prostaglandin E2, CHIR99021, and R-spondin), HGF, and EGF pathway (HGF, EGF), while inhibiting the TGFβ pathway (A83-01) and BMP pathway (Noggin), being grown on Matrigel.…”